Global Atopic Dermatitis Market Report: 2016 Edition - New Report by Koncept Analytics

1
Global Atopic Dermatitis Market Report
----------------------------------------- 2016
View Report Details
2
View Report Details

• Executive Summary
• The atopic dermatitis market is set to form a
  prominent segment of the pharmaceutical industry.
  Atopic dermatitis (AD) is a chronic, inflammatory
  skin disease of unknown origin that usually
  starts in early infancy, but also affects a
  substantial number of adults. Atopic dermatitis
  is a long lasting skin disease that affects a
  large percentage of the world's population and is
  a special type of hypersensitivity that is
  associated with asthma, inhalant allergies (hay
  fever), and a chronic dermatitis. The symptoms of
  atopic dermatitis are itching, red to brownish
  grey patches and small raised bumps.
• The main cause of atopic dermatitis is unknown
  but it is assumed to be caused due to genetics,
  dry skin and environmental conditions. Multiple
  factors can trigger or worsen atopic dermatitis,
  including low humidity, seasonal allergies,
  exposure to harsh soaps and detergents, and cold
  weather. There has been no specified biologic
  till now for atopic dermatitis. But recent
  efforts by many companies have shown positive
  results and the first biologic named as dupilumab
  may get launched in 2017. After that many other
  products are still in pipeline.
• The key factors which are anticipated to drive
  atopic dermatitis market include increase in
  global population, improvement in the global
  health care expenditure, accelerated economic
  growth, pollution and climatic factors and role
  of triggers. Some of the significant developments
  of this industry include introduction of new
  biologics, biomarker in atopic dermatitis and
  opportunity for new entrants. However, the
  challenge to be faced ahead is time to be taken
  in drug adoption, high price and legal
  regulations.
• This report offers a comprehensive analysis of
  the atopic dermatitis market. Furthermore, market
  dynamics such as key trends and development and
  challenges are analyzed in depth. On the
  contention front, the global stent market is
  reined by few major players namely Sanofi, Glaxo
  Smithkline (GSK), AstraZeneca and Roche Holding.
  The competitive landscape of the respective
  market, along with the company profiles of the
  leading players are also discussed in detail.

3
Increase in global population, rising healthcare
expenditure, pollution climatic factors, and
role of triggers will drive the global atopic
dermatitis market.

• The global atopic dermatitis market is expected
  to become active by 2017 with US.. million and
  is estimated to reach US..... million by 2025.
• As of 2015, there are .. million adults
  affected with atopic dermatitis globally which is
  expected to increase gradually and reach ..
  million by 2025.
• The number of adults diagnosed with atopic
  dermatitis globally is estimated to increase from
  . million in 2015 to .. million by 2025.
• There are .. thousands of adult patients in the
  US that are refractory to topical therapies and
  this number is estimated to increase to .
  thousands by 2025.

Global Atopic Dermatitis Treatment Forecast by
Value (2017E-2025E)
Global Adult Affected with Atopic Dermatitis by
Volume (2015-2025E)
Global Adult Diagnosed with Atopic Dermatitis by
Volume (2015-2025E)
4
Introduction of new biologics and the use of
biomarkers in atopic dermatitis market are the
latest developments and trends.
Global Adult with Moderate to Severe Atopic
Dermatitis (2015-2025E)

• The total number of adults suffering from
  moderate to severe atopic dermatitis is ..
  thousands in 2015 and is estimated to increase to
  thousands by 2025.
• There are .. thousands of adult patients
  globally that are refractory to topical therapies
  and this number is estimated to increase to .
  thousands by 2025.
• The revenue for atopic dermatitis market is
  estimated to increase from US..... million in
  2017 to US.... million by 2025 in the US.
• Over .. million adults in the European Union are
  affected with atopic dermatitis as of 2015. The
  number is expected to increase consistently to
  US..... million by 2025.

Global Adult Refractory to Topical Therapies
(2011-2017 E)
The US Atopic Dermatitis Treatment Forecast by
Value (2017E-2025E)
5
Time taken to adopt the drugs, high price and
legal regulations are the main challenges to the
atopic dermatitis market.
The US Adult Affected with Atopic Dermatitis
(2015-2025E)

• There are a total of . million adults affected
  with atopic dermatitis in the US and the number
  is expected to reach .. million by 2025.
• It is estimated that .. thousand patients would
  be treated in the US by 2017 and the number of
  treated patients is projected to reach ..
  thousand by 2025.
• It is estimated that .. thousand patients would
  be treated in the European Union by 2018 and the
  number of treated patients is projected to reach
  thousand by 2025.
• The number of adults diagnosed with atopic
  dermatitis in European Union is estimated to
  increase from .. million in 2015 to . million
  by 2025.

The US Treated Patients by Volume (2017E-2025E)
European Union Treated Patients by Volume
(2018E-2025E)
6
Contact Us
View Report Details
These are abridged and sanitized sample pages
from the comprehensive report on the Global
Atopic Dermatitis Market . To know more about
this report or for any customized research
requirement, please contact the following
Koncept Analytics CS-36, Second Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T.
91-120-4130959 C 91-9811715635
vikas_at_konceptanalytics.com
Vikas Gupta BD Manager
www.konceptanalytics.com